Press Release from NCI: NIH clinical trial will test precision medicine treatments for myeloid cancers

The latest press release from the National Cancer Institute

Having trouble viewing this email? View it as a Web page.

You are subscribed to Press Releases from the National Cancer Institute. New press releases are listed below.     NIH clinical trial will test precision medicine treatments for myeloid cancers 10/23/2024 NCI has launched myeloMATCH, a precision medicine treatment trial that will test treatment combinations targeting specific genetic changes in people with acute myeloid leukemia and myelodysplastic syndromes.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892